Hutchinson Michael Damon 4

What Happened
Michael Damon Hutchinson, EVP, Chief Legal Officer & Secretary of Integra Lifesciences Holdings Corp (IART), was granted 70,305 restricted stock units (RSUs) on March 11, 2026. The grant was reported as an award (derivative) at $0.00 on the Form 4 — no cash changed hands at the time of grant. The RSUs will convert into shares only as they vest.

Key Details

• Transaction date: 2026-03-11; Form 4 filed: 2026-03-12 (timely filing).
• Transaction type/code: Award (A) — restricted stock units (derivative).
• Quantity: 70,305 RSUs; acquisition price reported as $0.00.
• Vesting (footnote): 33% vests on the 1st and 2nd anniversaries, and 34% on the 3rd anniversary of the grant date (3/11/2026).
• Shares owned after transaction: Not disclosed in the filing.
• No tax-withholding sale or immediate disposition of underlying shares was reported.

Context
RSUs are compensatory awards that convert to actual shares (or cash equivalent) only upon vesting; they do not represent immediate ownership or an open-market purchase. Such grants are common long-term incentive compensation for executives and do not by themselves indicate a buying or selling signal.